Marc Van de Velde1. 1. Department of Cardiovascular Sciences, Department of Anesthesiology, UZ Leuven, KU Leuven, Leuven, Belgium.
Abstract
PURPOSE OF REVIEW: The purpose is to review the neonatal and maternal effects of remifentanil given at induction of general anesthesia for caesarean section and prior to delivery of the baby. MAIN FINDINGS: Remifentanil seems to have short-lived respiratory depressant effects in approximately 50% of neonates, requiring short periods of mask ventilation or tactile stimulation of the neonate. Remifentanil produces excellent maternal hemodynamic stability avoiding tachycardia and hypertension, possibly reducing the risk of maternal awareness. SUMMARY: Remifentanil can be safely used at induction of general anesthesia provided healthcare workers are available to manage short-lived neonatal depression.
PURPOSE OF REVIEW: The purpose is to review the neonatal and maternal effects of remifentanil given at induction of general anesthesia for caesarean section and prior to delivery of the baby. MAIN FINDINGS:Remifentanil seems to have short-lived respiratory depressant effects in approximately 50% of neonates, requiring short periods of mask ventilation or tactile stimulation of the neonate. Remifentanil produces excellent maternal hemodynamic stability avoiding tachycardia and hypertension, possibly reducing the risk of maternal awareness. SUMMARY:Remifentanil can be safely used at induction of general anesthesia provided healthcare workers are available to manage short-lived neonatal depression.